Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cysteine and histidine rich domain containing 1 (CHORDC1) is a zinc-binding co-chaperone protein that interacts with the molecular chaperone Hsp90 and possibly other partners, regulating key processes such as centrosome duplication, chaperone-mediated protein folding, Rho-dependent kinase activity, and particularly the maturation and trafficking of the epidermal growth factor receptor (EGFR). CHORDC1 ensures correct EGFR localization to the plasma membrane, thereby affecting downstream MAPK signaling, cell proliferation, and cytoskeletal organization. Its role is essential for cellular viability, and dysregulation contributes to impaired EGFR signaling, cytoskeletal abnormalities, and can modulate cancer susceptibility and progression. Drugs affecting chaperone activities, like geldanamycin, further highlight the therapeutic relevance of CHORDC1 in cancer and cell biology. CHORDC1 is broadly expressed across human tissues and has several conserved homologs and aliases.
Geldanamycin: Hsp90 inhibition decreases EGFR stability, especially in CHORDC1-deficient cells. Potential modulation of chaperone-mediated signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteine and histidine rich domain containing 1 (CHORDC1).